NCX-006

N/A

Report date: 2023/09/06 17:58:43
NME

Base Information

Drug NameNCX-006
Drug Alias NameNCX-006NCX006
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTiumBio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTiumBio Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A